To embed, copy and paste the code into your website or blog:
Our Antitrust and Health Care Groups examine the implications of the limited repeal of the McCarran–Ferguson Act by the just-signed Competitive Health Insurance Reform Act.
Only health and dental insurers are affected
Some conduct protected under McCarran–Ferguson remains protected
The new Act could change the outcome of some cases and foreshadow new aggressiveness from government enforcers
In a rare change to federal antitrust law, on January 13, 2021, the President signed into law legislation that eliminates some immunities for health insurers. The Competitive Health Insurance Reform Act of 2020, passed unanimously by the Senate, repeals portions of the McCarran–Ferguson Act, which protects certain activity that constitutes the “business of insurance” from antitrust liability. But the repeal – which only applies to health and dental insurers, and not property, casualty, life, or other insurers – is like
AAGL, in Partnership with Ten Leading Women’s Health Care Groups, Issue a Joint Statement Regarding the COVID-19 Vaccine
Share Article
The American Association of Gynecologic Laparoscopists (AAGL) announces their endorsement of the U.S. Food and Drug Administration (FDA) authorized Pfizer/BioNTech COVID-19 vaccine, for eligible populations, through a joint public health statement with ten respected women’s health medical societies. AAGL is an international professional medical association of laparoscopic surgeons and the global leader in minimally invasive gynecologic surgery.
Leading Women’s Health Care Groups, Issue a Joint Statement Regarding the COVID-19 Vaccine CYPRESS, Calif. (PRWEB) December 17, 2020 The American Association of Gynecologic Laparoscopists (AAGL), the American College of Obstetricians and Gynecologists (ACOG), the American Society for Reproductive Medicine (ASRM), American Urogynecolo